Revvity, Inc. (LON:0KHE)
94.56
-7.83 (-7.64%)
Feb 12, 2026, 4:50 PM GMT
Revvity Revenue
In the year 2025, Revvity had annual revenue of $2.86B USD with 3.67% growth. Revvity had revenue of $772.06M in the quarter ending December 28, 2025, with 5.85% growth.
Revenue
$2.86B
Revenue Growth
+3.67%
P/S Ratio
3.97
Revenue / Employee
$259.64K
Employees
11,000
Market Cap
8.40B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2025 | 2.86B | 101.03M | 3.67% |
| Dec 29, 2024 | 2.76B | 4.46M | 0.16% |
| Dec 31, 2023 | 2.75B | -561.25M | -16.95% |
| Jan 1, 2023 | 3.31B | -515.99M | -13.48% |
| Jan 2, 2022 | 3.83B | 1.16B | 43.73% |
| Jan 3, 2021 | 2.66B | -220.44M | -7.64% |
| Dec 29, 2019 | 2.88B | 105.68M | 3.80% |
| Dec 30, 2018 | 2.78B | 521.01M | 23.08% |
| Dec 31, 2017 | 2.26B | 141.47M | 6.69% |
| Jan 1, 2017 | 2.12B | 10.69M | 0.51% |
| Jan 3, 2016 | 2.10B | 34.94M | 1.69% |
| Dec 28, 2014 | 2.07B | -87.71M | -4.07% |
| Dec 29, 2013 | 2.16B | 52.40M | 2.49% |
| Dec 30, 2012 | 2.11B | 186.68M | 9.73% |
| Jan 1, 2012 | 1.92B | 216.74M | 12.74% |
| Jan 2, 2011 | 1.70B | 151.00M | 9.74% |
| Jan 3, 2010 | 1.55B | -108.90M | -6.56% |
| Dec 28, 2008 | 1.66B | -69.21M | -4.00% |
| Dec 30, 2007 | 1.73B | 251.19M | 17.00% |
| Dec 31, 2006 | 1.48B | 3.85M | 0.26% |
| Jan 1, 2006 | 1.47B | 44.74M | 3.13% |
| Jan 2, 2005 | 1.43B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
Revvity News
- 7 days ago - Revvity Unveils New High-Impact Discovery Platforms and Showcases Recent Innovations at SLAS2026 - Business Wire
- 9 days ago - Revvity: Close To A Buy, Not Quite There - Seeking Alpha
- 9 days ago - JP Morgan Raises Revvity (RVTY) Price Target to $105.00 | RVTY Stock News - GuruFocus
- 9 days ago - Transcript: Q 2026 Earnings Conference Call - Benzinga
- 9 days ago - Revvity (RVTY) Receives Price Target Boost from Evercore ISI Group | RVTY Stock News - GuruFocus
- 9 days ago - Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
- 9 days ago - Revvity Analysts Boost Their Forecasts Following Better-Than-Expected Q4 Results - Benzinga
- 9 days ago - Revvity (RVTY) Maintains Hold Rating, Price Target Raised to $105 by Jefferies | RVTY Stock News - GuruFocus